In an entry-level pharmaceutical sales resume, write acareer objective statement. In the days before aspirin, that was where you talked about your dreams to have a pharma sales career. But things have changed. Today, share your dreams about how you’ll help the drug company succeed. If you...
Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI ...
Indeed, a near-consensus is emerging in favor of explainable AI/ML among academics, governments, and civil society groups. Many are drawn to this approach to harness the accuracy benefits of noninterpretable AI/ML such as deep learning or neural nets while also supporting transparency, trust, ...
India, which has the world's third largest pharmaceutical industry, rep- resents a smaller yet still sizeable share of global antibiotic API manufacturing. Indian companies have also positioned themselves as leaders in the production of 'finished dose' antibiotic products using APIs mainly imported ...
March 1 - Moderna:The big biotech is laying off employees within its manufacturing unit, with the move tied to a resizing of its COVID production work. The Moderna rep declined to say how many employees would be affected.Story February—16 companies ...
Sci. Rep. 2017;(7)1. Wen H, He B, Wang H, Chen F, Li P, Cui M, et al. Structure-based gastro-retentive and controlled-release drug delivery with novel 3D printing. AAPS PharmSciTech. 2019;20(2):68. Article CAS PubMed Google Scholar Amidon S, Brown JE, Dave VS. Colon-...
and political human structures capable to responding to all the challenges inherent to each industry (Bernon et al.2018; Mahadevan2019; Paula et al.2019). Solid coordination between retailers in different industries and their clients is required to harmonize sales and consumption. Likewise, vertical...
Although global sales of OVs are still in the ramp-up phase, some projections forecast OVs will be a $700 million market by 2026. This panel will address some of the major questions in this area: What regulatory challenges will keep OVs from realizing their potential? Despite the promise of...
Sci Rep . Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors Tung-Ju Hsieh 1, Hsien-Ya Lin 1 2, Zhijay Tu 1, Ting-Chien Lin 1 2, Shang-Chuen Wu 1 3, Yu-Yao Tseng 1, Fu-Tong Liu 4, Shang-Te Da...
Chief Research & Development Officer, Replimune 2002 in UK promise in oncolytic therapy GNCSF Phase III melanoma 2015 M&A with Amgen oncolytic therapy remains non effecting on immune response data is key for commercialization do not belief in systemic therapy achieve maximum immune response possibl...